Therefore, studies analyzing the genetic and epigenetic modulation of ABCG1 in populations of patients with hepatosteatosis or NASH will greatly help to evaluate the contribution of ABCG1 expression in NAFLD. This evidence concerns the gene ABCG1 and metabolic dysfunction-associated steatohepatitis.